研究AI方法用于预测慢性淋巴细胞白血病的生存率
Abdelmalek Mouazer1,2, Edgar Degroodt1,2, Florence Nguyen-Khac3,4
1Sorbonne Université, Université Sorbonne Paris Nord, INSERM, Limics, Paris, France.
Studies in health technology and informatics
|April 9, 2025
概括
机器学习模型准确地预测慢性淋巴细胞白血病 (CLL) 的生存率. 随机生存森林和决策树模型比传统方法表现优越,提供个性化的预后见解.
科学领域:
- 血液学 血液学 血液学
- 计算生物学 计算生物学
- 在瘤学瘤学.
背景情况:
- 慢性淋巴细胞白血病 (CLL) 呈现出一个可变的临床轨迹.
- 确定可靠的预后标志物对于患者管理至关重要.
- 已知MYC基因异常会影响CLL的结果.
研究的目的:
- 评估机器学习 (ML) 模型来预测CLL的生存率.
- 为了比较随机生存森林 (RSF),决策树 (DT) 和Cox比例危险模型的预测准确度.
- 评估MYC阳性和一般的CLL患者队列中的模型性能.
主要方法:
- 研究了三种时间到事件的结果:诊断后的10年生存率,细胞遗传学评估后的10年生存率和第一次治疗的时间.
- 用RSF,DT和Cox的比例危险模型来预测生存率.
- 使用C指数和曲线下的面积 (AUC) 度量来评估模型性能.
主要成果:
- 与Cox模型相比,RSF和DT模型显示出更高的预测准确性.
- 关键的预测变量被确定使用顺序重要性.
- 虽然RSF和DT提供了更高的准确性,但Cox模型通过危险比率提供了更清晰的解释性.
结论:
- 机器学习模型,特别是RSF和DT,在CLL中显示出个性化生存预测的重大前景.
- 这些模型对于MYC阳性CLL病例尤其有价值.
- 进一步完善ML模型可以提高其临床实用性和适用性.
更多相关视频
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.0K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
20.9K
相关概念视频
Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
Actuarial Approach
49
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
49
Kaplan-Meier Approach
60
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
60
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Assumptions of Survival Analysis
71
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
71
